This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jun 20;25(18):2625-6; author reply 2627-8.

doi: 10.1200/JCO.2007.11.5014.

Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?

Adriana Balduzzi, Valentino Conter, Cornelio Uderzo, Maria Grazia Valsecchi

PMID: 17577046
DOI: 10.1200/JCO.2007.11.5014

Comment

Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?

Adriana Balduzzi et al. J Clin Oncol. 2007.

. 2007 Jun 20;25(18):2625-6; author reply 2627-8.

doi: 10.1200/JCO.2007.11.5014.

Authors

Adriana Balduzzi, Valentino Conter, Cornelio Uderzo, Maria Grazia Valsecchi

PMID: 17577046
DOI: 10.1200/JCO.2007.11.5014

No abstract available

PubMed Disclaimer

Comment on

Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G. Ribera JM, et al. J Clin Oncol. 2007 Jan 1;25(1):16-24. doi: 10.1200/JCO.2006.06.8312. J Clin Oncol. 2007. PMID: 17194902 Clinical Trial.

Similar articles

Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G. Ribera JM, et al. J Clin Oncol. 2007 Jan 1;25(1):16-24. doi: 10.1200/JCO.2006.06.8312. J Clin Oncol. 2007. PMID: 17194902 Clinical Trial.
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Balduzzi A, De Lorenzo P, Schrauder A, Conter V, Uderzo C, Peters C, Klingebiel T, Stary J, Felice MS, Magyarosy E, Schrappe M, Dini G, Gadner H, Valsecchi MG. Balduzzi A, et al. Haematologica. 2008 Jun;93(6):925-9. doi: 10.3324/haematol.12291. Epub 2008 Apr 15. Haematologica. 2008. PMID: 18413892
Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?
Willemze R, Labar B. Willemze R, et al. Semin Hematol. 2007 Oct;44(4):267-73. doi: 10.1053/j.seminhematol.2007.08.004. Semin Hematol. 2007. PMID: 17961726 Review.
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V; Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Fouillard L, et al. Haematologica. 2008 Jun;93(6):834-41. doi: 10.3324/haematol.11277. Epub 2008 May 10. Haematologica. 2008. PMID: 18469352
Allogeneic bone marrow transplantation versus chemotherapy in childhood very high risk acute lymphoblastic leukemia in first complete remission: a controversial issue.
Uderzo C, Balduzzi A. Uderzo C, et al. Haematologica. 2002 Aug;87(8 Suppl):47-50. Haematologica. 2002. PMID: 12412390 Review.

See all similar articles

Cited by

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.
Brissot E, Rialland F, Cahu X, Strullu M, Corradini N, Thomas C, Blin N, Rialland X, Thebaud E, Chevallier P, Moreau P, Milpied N, Harousseau JL, Mechinaud F, Mohty M. Brissot E, et al. Bone Marrow Transplant. 2016 Feb;51(2):267-72. doi: 10.1038/bmt.2015.250. Epub 2015 Dec 7. Bone Marrow Transplant. 2016. PMID: 26642337 Clinical Trial.
Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center.
Khan S, Siddiqui K, ElSolh H, AlJefri A, AlAhmari A, Ghemlas I, AlSaedi H, AlEnazi A, AlSeraihi A, Ayas M. Khan S, et al. Int J Pediatr Adolesc Med. 2022 Dec;9(4):190-195. doi: 10.1016/j.ijpam.2022.09.002. Epub 2022 Sep 30. Int J Pediatr Adolesc Med. 2022. PMID: 36937328 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.